Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked.
Source: CNBC
Monday, 23. February 2026
Share:
23. February 2026 18:49
Eli Lilly's lead in the obesity race gets wider after another win against rival Novo Nordisk
